![Bernard Mach](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bernard Mach
Fondateur chez
Release Therapeutics SA
Profil
Bernard Mach is the founder of NovImmune SA, founded in 1998, and MaxiVAX SA, founded in 2005 where he holds the title of Director.
He also held the position of Deputy Chairman at Lonza Group AG and was a Director at Serono SA from 1997 to 2007.
Additionally, he was a Professor at the University of Geneva.
Dr. Mach is also the founder of LO FUNDS LIFE SCIENCES EXPERTISE, Biogen MA, Inc. He holds a doctorate degree from The Rockefeller University and the University of Geneva.
Postes actifs de Bernard Mach
| Sociétés | Poste | Début |
|---|---|---|
Release Therapeutics SA
 Release Therapeutics SA BiotechnologyHealth Technology Develops first cell microencapsulation technology to deliver therapeutic proteins beyond the human blood-brain barrier | Fondateur | 01/01/2005 |
Anciens postes connus de Bernard Mach
| Sociétés | Poste | Fin |
|---|---|---|
LO FUNDS LIFE SCIENCES EXPERTISE
 LO FUNDS LIFE SCIENCES EXPERTISE Investment Trusts/Mutual FundsMiscellaneous Open-End Investment Fund/Unit Trust | Fondateur | 28/03/2014 |
Serono SA
 Serono SA Pharmaceuticals: MajorHealth Technology Specializes in the manufacture of cancer and cardiovascular drugs | Directeur/Membre du Conseil | 17/01/2007 |
University of Geneva
 University of Geneva Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/1998 |
| NOVIMMUNE SA | Fondateur | - |
| LONZA GROUP AG | Directeur/Membre du Conseil | - |
Formation de Bernard Mach
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
25
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Develops and manufactures drugs related to immunology, neurobiology and oncology | Health Technology |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Specializes in the manufacture of cancer and cardiovascular drugs | Health Technology |
Lonza Group AG
 Lonza Group AG BiotechnologyHealth Technology Develops and manufactures, biologics, biopharmaceuticals, small molecules & health ingredients | Health Technology |
LO FUNDS LIFE SCIENCES EXPERTISE
LO FUNDS LIFE SCIENCES EXPERTISE Investment Trusts/Mutual FundsMiscellaneous Open-End Investment Fund/Unit Trust | Miscellaneous |
The Rockefeller University
 The Rockefeller University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Geneva
University of Geneva Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novimmune SA
 Novimmune SA BiotechnologyHealth Technology Operates as a drug discovery and development company | Health Technology |
Release Therapeutics SA
Release Therapeutics SA BiotechnologyHealth Technology Develops first cell microencapsulation technology to deliver therapeutic proteins beyond the human blood-brain barrier | Health Technology |
